Direct-to-consumer marketing of psychological treatments for anxiety disorders

•We discuss the application of direct-to-consumer advertising efforts to promote evidence-based care in the treatment of anxiety disorders.•We review current direct-to-consumer efforts for anxiety disorder treatment.•We make recommendations for future efforts in the direct-to-consumer marketing of evidence-based psychological treatments for anxiety.

Progress disseminating and implementing evidence-based psychological treatments (EBPTs) for the anxiety disorders has been gradual. To date, the dominant approach for promoting the uptake of EBPTs in clinical settings has been to target the education and training of mental health providers, with many consumers remaining unaware of the potential benefits of EBPTs for anxiety disorders. Direct-to-consumer (DTC) marketing may be a promising vehicle for increasing EBPT utilization rates in the treatment of anxiety disorders. This paper provides an overview of the rationale and important considerations for applying DTC efforts to promote evidence-based care in the treatment of anxiety disorders, and reviews current DTC efforts in this area, including resources on the Internet and other media and in-person events. We conclude with recommendations for future efforts in the DTC marketing of EBPTs for the anxiety disorders, including the need for increased funding and grassroots efforts to inform consumers about anxiety disorders and their most effective treatments.